BioHarvest Sciences Inc. Common Stock (BHST) is a Agricultural inputs company in the Basic materials sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for BioHarvest Sciences Inc. Common Stock in 2026. The next earnings report is expected on November 30, 2026.
Next earnings date
30 Nov 2026
In 102 days
EPS estimate
-0.10
Revenue estimate
11.4M
Past earnings
Latest earnings analysis
BioHarvest Sciences missed consensus estimates in its latest earnings report, with EPS of -$0.17 versus an estimate of -$0.1175 and revenue of $8.84 million, which fell 6.5% short of expectations. In the prior report EPS came in ahead of expectations while revenue essentially met estimates.
No dividend history available.
BioHarvest Sciences Inc. functions as a biotechnology firm with operations segmented into Nutraceuticals and Pharmaceuticals. A key innovation is its proprietary botanical synthesis platform technology, which allows for the cultivation of active ingredients found within plant enzymes or cells. The company harnesses this advanced technology to craft evidence-based and clinically validated therapeutic products for both its nutraceutical and pharmaceutical offerings. Beyond its own development, it also provides contract development and manufacturing services. Its product portfolio includes various wellness items, notably VINIA, a dietary supplement derived from red grape cells, which delivers the full spectrum of polyphenols naturally present in red grapes. The company conducts business in Israel and the United States, with its corporate base in Vancouver, Canada.
BioHarvest Sciences Inc. Common Stock (BHST) is scheduled to report earnings on November 30, 2026.
BioHarvest Sciences Inc. Common Stock (BHST) last reported earnings on August 11, 2026.
BioHarvest Sciences Inc. Common Stock (BHST) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.